397 related articles for article (PubMed ID: 18983306)
1. Establishing an oral anticoagulant monitoring service in a multiethnic developing country.
Casimire T; Carter R; Peters S; Tweedle J; Charles KS
Int J Lab Hematol; 2008 Dec; 30(6):531-5. PubMed ID: 18983306
[TBL] [Abstract][Full Text] [Related]
2. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
Crowther MA
Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
[TBL] [Abstract][Full Text] [Related]
3. Management of oral anticoagulant treatment in patients with venous thromboembolism.
Pengo V
Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
[TBL] [Abstract][Full Text] [Related]
4. [Recommended use of INR in the laboratory monitoring of oral anticoagulant treatment].
Syrjälä M
Duodecim; 1998; 114(6):573-5. PubMed ID: 11466922
[No Abstract] [Full Text] [Related]
5. International Normalized Ratio (INR): an improved way to monitor oral anticoagulant therapy.
Oertel LB
Nurse Pract; 1995 Sep; 20(9):15-6, 21-2. PubMed ID: 7501312
[TBL] [Abstract][Full Text] [Related]
6. Audit of community-based anticoagulant monitoring in patients with thromboembolic disease: is frequent testing necessary?
Young L; Ockelford P; Harper P
Intern Med J; 2004 Nov; 34(11):639-41. PubMed ID: 15546458
[TBL] [Abstract][Full Text] [Related]
7. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
[TBL] [Abstract][Full Text] [Related]
8. Home prothrombin time monitoring: a literature analysis.
Yang DT; Robetorye RS; Rodgers GM
Am J Hematol; 2004 Oct; 77(2):177-86. PubMed ID: 15389909
[TBL] [Abstract][Full Text] [Related]
9. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
[TBL] [Abstract][Full Text] [Related]
10. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
[TBL] [Abstract][Full Text] [Related]
11. Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants.
Liew A; Eikelboom JW; O'Donnell M; Hart RG
Can J Cardiol; 2013 Jul; 29(7 Suppl):S34-44. PubMed ID: 23790596
[TBL] [Abstract][Full Text] [Related]
12. [Monitoring for oral anticoagulant therapy].
Nakagawa K; Nakahara Y; Tsuji H
Rinsho Ketsueki; 1995 Apr; 36(4):308-13. PubMed ID: 7783335
[TBL] [Abstract][Full Text] [Related]
13. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
Rombouts EK; Rosendaal FR; van der Meer FJ
Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
[TBL] [Abstract][Full Text] [Related]
14. Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial.
Siebenhofer A; Rakovac I; Kleespies C; Piso B; Didjurgeit U
Thromb Haemost; 2007 Mar; 97(3):408-16. PubMed ID: 17334508
[TBL] [Abstract][Full Text] [Related]
15. Falsely elevated INRs in warfarin-treated patients with the lupus anticoagulant.
Sanfelippo MJ; Sennet J; McMahon EJ
WMJ; 2000 Jun; 99(3):62-4, 43. PubMed ID: 10927985
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin.
Bauman ME; Black KL; Massicotte MP; Bauman ML; Kuhle S; Howlett-Clyne S; Cembrowski GS; Bajzar L
Thromb Haemost; 2008 Jun; 99(6):1097-103. PubMed ID: 18521514
[TBL] [Abstract][Full Text] [Related]
17. Home INR monitoring of oral anticoagulant therapy in children using the CoaguChek S point-of-care monitor and a robust education program.
Newall F; Monagle P; Johnston L
Thromb Res; 2006; 118(5):587-93. PubMed ID: 16168465
[TBL] [Abstract][Full Text] [Related]
18. Warfarin monitoring by an anticoagulant therapy factor (ATF).
Carroll WE; Jackson RD; Carroll TA
Res Commun Mol Pathol Pharmacol; 1998 Aug; 101(2):159-70. PubMed ID: 9821212
[TBL] [Abstract][Full Text] [Related]
19. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
Tripodi A; Breukink-Engbers WG; van den Besselaar AM
Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
[TBL] [Abstract][Full Text] [Related]
20. Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management.
Phillips KW; Ansell J
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):57-70. PubMed ID: 18095907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
